Literature DB >> 14522305

ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy.

Kensaku Miyake1, Nobuhiro Ibaraki, Yoko Goto, Shin Oogiya, Junko Ishigaki, Ichiro Ota, Sampei Miyake.   

Abstract

Many antiglaucoma eyedrops are reported to cause cystoid macular edema (CME) in aphakia and pseudophakia. We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. Based on the findings of these studies, which indicate that the preservative causes increased synthesis of PGs and other substances and intensified postoperative inflammation, the term pseudophakic preservative maculopathy is proposed for CME caused by antiglaucoma eyedrops.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522305     DOI: 10.1016/s0886-3350(03)00560-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  14 in total

1.  Survey of perioperative prostaglandin analogue administration during cataract surgery in Greece.

Authors:  Asimina Mataftsi; Konstantinos T Tsaousis; Ioannis T Tsinopoulos; Stavros A Dimitrakos
Journal:  Int Ophthalmol       Date:  2012-03-20       Impact factor: 2.031

2.  Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy.

Authors:  Y Kitazawa; P Smith; N Sasaki; S Kotake; K Bae; Y Iwamoto
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

3.  Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification.

Authors:  Elena Milla; Oana Stirbu; Isabel Jimenez Franco; Santiago J García Hernández; Jose Rios; Susana Duch
Journal:  Int Ophthalmol       Date:  2016-10-22       Impact factor: 2.031

4.  Handling test of eye drop dispenser--comparison of unit-dose pipettes with conventional eye drop bottles.

Authors:  Minna Parkkari; Terho Latvala; Auli Ropo
Journal:  J Ocul Pharmacol Ther       Date:  2010-06       Impact factor: 2.671

5.  Cystoid macular oedema within 24 h after a single application of latanoprost.

Authors:  Vlassis G Grigoropoulos; Ioannis Emfietzoglou; Pantelis Nikolaidis; Panagiotis G Theodossiadis; George P Theodossiadis
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

6.  Travoprost in the management of open-angle glaucoma and ocular hypertension.

Authors:  Philippe Denis; David Covert; Anthony Realini
Journal:  Clin Ophthalmol       Date:  2007-03

7.  In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).

Authors:  Christophe Baudouin; Alexandre Denoyer; Nicolas Desbenoit; Gregory Hamm; Alice Grise
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

8.  [Preservatives in ophthalmology].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

Review 9.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

10.  A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits.

Authors:  Françoise Brignole-Baudouin; Nicolas Desbenoit; Gregory Hamm; Hong Liang; Jean-Pierre Both; Alain Brunelle; Isabelle Fournier; Vincent Guerineau; Raphael Legouffe; Jonathan Stauber; David Touboul; Maxence Wisztorski; Michel Salzet; Olivier Laprevote; Christophe Baudouin
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.